|Characterization and structural analysis of HIV-1 integrase conservation|
F Ceccherini-Silberstein, I Malet, R D’Arrigo, A Antinori, AG Marcelin, ...
Aids Rev 11 (1), 17-29, 2009
|HIV-1 and HCV sequences from Libyan outbreak|
T De Oliveira, OG Pybus, A Rambaut, M Salemi, S Cassol, M Ciccozzi, ...
Nature 444 (7121), 836-837, 2006
|An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus|
D Maione, C Della Rocca, P Giannetti, R D'Arrigo, L Liberatoscioli, ...
Proceedings of the National Academy of Sciences 98 (11), 5986-5991, 2001
|Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment|
S Aquaro, R D'Arrigo, V Svicher, GD Perri, SL Caputo, U Visco-Comandini, ...
Journal of antimicrobial chemotherapy 58 (4), 714-722, 2006
|Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure|
F Ceccherini-Silberstein, F Erba, F Gago, A Bertoli, F Forbici, ...
Aids 18 (12), 11-19, 2004
|Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing|
D Armenia, I Vandenbroucke, L Fabeni, H Van Marck, V Cento, R D’Arrigo, ...
Journal of Infectious Diseases 205 (4), 557-567, 2012
|Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels|
MM Santoro, L Fabeni, D Armenia, C Alteri, D Di Pinto, F Forbici, A Bertoli, ...
Clinical infectious diseases 58 (8), 1156-1164, 2014
|High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations|
F Ceccherini-Silberstein, F Gago, M Santoro, C Gori, V Svicher, ...
Journal of virology 79 (16), 10718-10729, 2005
|Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors|
F Ceccherini-Silberstein, I Malet, L Fabeni, S Dimonte, V Svicher, ...
Journal of antimicrobial chemotherapy 65 (11), 2305-2318, 2010
|Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group|
V Svicher, R D'Arrigo, C Alteri, M Andreoni, G Angarano, A Antinori, ...
|Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120 V3 signatures in the regulation of co-receptor usage|
S Dimonte, F Mercurio, V Svicher, R D'Arrigo, CF Perno, ...
Retrovirology 8 (1), 1-11, 2011
|Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz …|
V Tozzi, M Zaccarelli, P Narciso, MP Trotta, F Ceccherini-Silberstein, ...
The Journal of infectious diseases 189 (9), 1688-1695, 2004
|Specific Enfuvirtide-Associated Mutational Pathways in HIV-1 Gp41 Are Significantly Correlated With an Increase in CD4+ Cell Count, Despite Virological Failure|
S Valentina, S Aquaro, R D'Arrigo, A Artese, S Dimonte, S Alcaro, ...
The Journal of infectious diseases 197 (10), 1408-1418, 2008
|Subtype analysis and mutations to antiviral drugs in HIV‐1‐infected patients from Mozambique before initiation of antiretroviral therapy: Results from the DREAM programme|
MC Bellocchi, F Forbici, L Palombi, C Gori, E Coelho, V Svicher, ...
Journal of medical virology 76 (4), 452-458, 2005
|Molecular diversity of HIV in Albania|
M Ciccozzi, C Gori, S Boros, MJ Ruiz-Alvarez, A Harxhi, M Dervishi, ...
The Journal of infectious diseases 192 (3), 475-479, 2005
|Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy|
M Zaccarelli, CF Perno, F Forbici, F Soldani, S Bonfigli, C Gori, MP Trotta, ...
Clinical infectious diseases 38 (3), 433-437, 2004
|Macrophages: a crucial reservoir for human immunodeficiency virus in the body.|
E Balestra, CF Perno, S Aquaro, S Panti, A Bertoli, M Piacentini, F Forbici, ...
Journal of biological regulators and homeostatic agents 15 (3), 272-276, 2001
|Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon|
J Fokam, R Salpini, MM Santoro, V Cento, R D’Arrigo, C Gori, CF Perno, ...
Archives of virology 156 (7), 1235-1243, 2011
|Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs|
C Alteri, V Svicher, C Gori, R D'Arrigo, M Ciccozzi, ...
BMC Infectious Diseases 9 (1), 1-11, 2009
|HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro|
V Svicher, E Balestra, V Cento, L Sarmati, L Dori, I Vandenbroucke, ...
Antiviral research 90 (1), 42-53, 2011